Reminds me of early 08 when Goldman bought 1 million shares then a few months later doubled it. As I recall all the regular tards danced daily with posts detailing exactly how they were going to spend their millions. Course, by fall of 08 Geron was at $1.95 and the Goldman position vanished.
In addition the author of the thread, Taz, has literally been wrong with every prediction ever made. Every single prediction. If I'm wrong prove it.
I was just looking at my charts and one of my stochastic screens shows GERN almost oversold while the other one shows it almost overbought. I don't ofter see this. The two sets of parametrics usual track one another very well.
At $1.52, and with the current 163L results, GERN just may be an interesting "risk" trade.
I did a little research in to the Baker bros. They are in the top ten best performing hedge funds for 2012. They focus almost exclusively on biotech. They buy at the bottom (4th qrt GERN hit an all time low). They are long term holders. Typically 3 years. Their picks usually get bought out by large pharma. They are very secretive and do NOT do interviews. Lots of traders follow them through the fund's quarterly filings. It appears that these guys know what they are doing to such an extent that many traders and biotech analysts are watching them very closely.
You don't need to know anything special. everything is already in the data. response could be meaured objectively bacause of the genetic marker. Response was robust and sustainable (over a year). There are 70-75 thou ET patients in US alone, and this seems to be a great med for them. I bought some GERN.